−62.9
IRulya Therapeutics Inc. (QNCX)
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−44.0
FY23:
−18.3
FY24:
−31.9
FY25:
−41.4
Change from FY21 to FY25
millions USD
FY21:
59.0
FY22:
18.0
FY23:
−5.76
FY24:
21.9
FY25:
23.2
Change from FY21 to FY25
millions USD
FY21:
6.81
FY22:
0.71
FY23:
0.14
FY24:
−4.78
FY25:
17.9
millions USD
FY21:
2.88
FY22:
−25.1
FY23:
−23.8
FY24:
−14.5
FY25:
−0.40
(positive)
Change from FY21 to FY25
millions USD
FY21:
−63.1
FY22:
−44.2
FY23:
−18.5
FY24:
−32.2
FY25:
−41.8
All amounts in millions USD